Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AZTR
AZTR logo

AZTR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Azitra Inc (AZTR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.150
1 Day change
2.02%
52 Week Range
1.830
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

AZTR is not a good buy right now for a beginner focused on long-term investing, even with $50,000-$100,000 available. The stock is trading in a weak technical setup, there is no supportive news or bullish proprietary signal, and there is no evidence of strong fundamental momentum. For an impatient investor looking to act now rather than wait for a better entry, this is still not an attractive purchase.

Technical Analysis

The trend is bearish. MACD histogram is negative and worsening, indicating downside momentum. RSI_6 at 30.439 is near oversold but not yet a clear reversal signal. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, showing the stock remains below longer-term trend strength. Price at 0.1551 is sitting just under the key support area around S1 at 0.156, which means the stock is testing a fragile support zone rather than confirming an uptrend.

Positive Catalysts

  • No recent news in the last week, no recent congress trading data, and no significant insider or hedge fund accumulation trends. The only mild positive is the stock trend model suggesting a possible short-term rebound probability, but this is not strong enough to outweigh the broader weakness.

Neutral/Negative Catalysts

  • No news-driven catalyst is present. Hedge funds are neutral, insiders are neutral, and there are no significant trading trends over the last quarter or month. The stock is also down on the regular session, and the technical structure remains bearish. AI Stock Pick has no signal, and SwingMax has no recent signal.

Financial Performance

No usable latest quarter financial data was provided because the financial snapshot returned an error. As a result, there is no evidence here of accelerating revenue or earnings growth to support a long-term buy case. Latest quarter season could not be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible Wall Street upgrade trend or bullish consensus to support the stock. Based on the available information, Wall Street support appears limited rather than constructive.

Wall Street analysts forecast AZTR stock price to rise
Analyst Rating
0
Wall Street analysts forecast AZTR stock price to rise
Buy
Hold
Sell
0
Current: 0.149
sliders
Low
0
Averages
0
High
0
0
Current: 0.149
sliders
Low
0
Averages
0
High
0
Maxim
Buy
downgrade
$4
AI Analysis
2025-09-24
Reason
Maxim
Price Target
$4
AI Analysis
2025-09-24
downgrade
Buy
Reason
Maxim lowered the firm's price target on Azitra to $4 from split-adjusted $13.32 and keeps a Buy rating on the shares. The firm is citing its expectations of dilution in cutting its price target as the company addresses capital needs to advance ATR-12 and ATR-04 forward in clinical development, the analyst tells investors in a research note. Maxim adds however that Azitra's lead program ATR-12 in Netherton syndrome reported positive initial safety data in June, and if positive, its ongoing Phase 1 trial could be a key catalyst for shares.

People Also Watch